Sponsor Pipeline

Wuhan Optics Valley Vcanbiopharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT06230822
Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary…		 Trial completed
2026-08-01 NCT06230822
Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary…		 date change Primary completion pushed: 2025-01 -> 2025-03-13
2026-08-01 NCT06230822
Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary…		 date change Completion moved earlier: 2026-12 -> 2025-08-01
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06677255 A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host… Steroid-refractory Acute Graft-versus-host Disease Not Yet Recruiting
Get alerts when Wuhan Optics Valley Vcanbiopharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free